Evidence map›Paper›PMID 40349203›Full record

ArticleJournal of public health (Oxford, England)2025

Evaluation of an authorized nurse immunizer led opportunistic patient influenza and COVID-19 vaccination program under the RE-AIM framework.

Sarah Davies, Kathryn Taylor, Donna Moore

Abstract read
In one paragraph

Article in Journal of public health (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sarah DaviesPublic Health Unit, Central Coast Local Health District, 77a Holden Street, Gosford 2250, NSW, Australia.ORCID 0000-0003-1487-5863
Kathryn TaylorPublic Health Unit, Central Coast Local Health District, 77a Holden Street, Gosford 2250, NSW, Australia.
Donna MoorePublic Health Unit, Central Coast Local Health District, 77a Holden Street, Gosford 2250, NSW, Australia.

Funding

NSW Health Public Health Officer TraineeshipPublic Health Association of Australia
6 · The paper itself

Abstract

backgroundInfluenza and COVID-19 are significant vaccine-preventable causes of morbidity, mortality, and healthcare costs. Hospital-based, nurse-led models can increase vaccine uptake, yet few target adults. This study evaluates the implementation of an opportunistic patient influenza and COVID-19 vaccination program in the Central Coast Local Health District (CCLHD), led by Authorized Nurse Immunizers (ANIs).

methodsEvaluation of the ANI-led program was conducted using the RE-AIM (reach, effectiveness, adoption, implementation, and maintenance) framework. The 10-week program involved screening patients for vaccine eligibility, offering vaccinations and collecting quantitative data and qualitative feedback across the five RE-AIM domains.

resultsOf 849 patients screened alongside service encounters, 398 were vaccinated with 76% of eligible patients consenting to flu and 59% to COVID-19 vaccination. Inpatients had lower vaccination rates on admission compared to the general population and higher rates after program contact. The program was well received by patients and staff and adopted across various CCLHD settings, effectively addressing community access barriers.

conclusionsOpportunistic vaccination using an ANI-led model is an effective strategy to improve vaccination coverage among higher-risk patients. This evaluation demonstrates the benefits of a dedicated nurse immunizer workforce and suggests potential for broader adoption in similar healthcare settings to improve public health outcomes.

Indexed as

COVID-19COVID-19 VaccinesImmunization ProgramsInfluenza, HumanInfluenza VaccinesVaccinationAdultAgedFemaleHumansMaleMiddle AgedProgram EvaluationSARS-CoV-2COVID-19 VaccinesInfluenza Vaccinesimmunisationmodelspublic health

Identifiers

PMID40349203
PMCPMC12395946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.